Intangible Assets (Tables)

12 Months Ended

Oct. 31, 2019

Goodwill and Intangible Assets Disclosure [Abstract]

Goodwill



(In millions)	CooperVision			CooperSurgical			Total
Balance at October 31, 2017	$	1,735.7		$	619.1		$	2,354.8
Net additions during the year ended October 31, 2018	36.8			34.4			71.2
Translation	(29.6		)	(4.3		)	(33.9		)
Balance at October 31, 2018	$	1,742.9		$	649.2		$	2,392.1
Net additions during the year ended October 31, 2019	14.1			22.0			36.1
Translation	8.4			(7.7		)	0.7
Balance at October 31, 2019	$	1,765.4		$	663.5		$	2,428.9

Schedule of finite-lived intangible assets

Other Intangible Assets



	October 31, 2019				October 31, 2018
(In millions)	Gross Carrying Amount		Accumulated Amortization & Translation		Gross Carrying Amount ⁽¹⁾		Accumulated Amortization & Translation ⁽¹⁾		Weighted Average Amortization Period (In years)
Intangible assets with definite lives:
Trademarks	$	148.5	$	27.3	$	138.1	$	16.9	14
Composite intangible asset	1,061.9		141.6		1,061.9		70.8		15
Technology	399.9		221.2		387.2		190.7		11
Customer relationships	357.6		194.0		350.0		168.6		13
License and distribution rights and other ⁽²⁾	27.9		15.3		74.9		52.7		11
	1,995.8		$	599.4	2,012.1		$	499.7	14
Less: accumulated amortization and translation	599.4				499.7
Intangible assets with definitive lives, net	$	1,396.4			$	1,512.4

Intangible assets with indefinite lives, net ⁽³⁾	8.9				8.9

Total other intangible assets, net	$	1,405.3			$	1,521.3

⁽¹⁾In the second quarter of fiscal 2018, CooperSurgical recognized an impairment charge of $24.4 million upon the intangible assets on the exit of the carrier screening and non-invasive prenatal testing (NIPT) product lines acquired from Recombine Inc. in fiscal 2016. The intangible assets impaired consisted of Technology, Trademark and Customer relationships.

⁽²⁾In the second quarter of fiscal 2019, CooperSurgical sold an exclusive distribution right to distribute Filshie Clip System in the U.S. for $21.0 million and recognized a gain of $19.0 million. In the third quarter of fiscal 2019, CooperVision removed $37.3 million of fully amortized non-compete agreements.

⁽³⁾Intangible assets with indefinite lives include trademark and technology intangible assets.

Schedule of indefinite-lived intangible assets

Other Intangible Assets



	October 31, 2019				October 31, 2018
(In millions)	Gross Carrying Amount		Accumulated Amortization & Translation		Gross Carrying Amount ⁽¹⁾		Accumulated Amortization & Translation ⁽¹⁾		Weighted Average Amortization Period (In years)
Intangible assets with definite lives:
Trademarks	$	148.5	$	27.3	$	138.1	$	16.9	14
Composite intangible asset	1,061.9		141.6		1,061.9		70.8		15
Technology	399.9		221.2		387.2		190.7		11
Customer relationships	357.6		194.0		350.0		168.6		13
License and distribution rights and other ⁽²⁾	27.9		15.3		74.9		52.7		11
	1,995.8		$	599.4	2,012.1		$	499.7	14
Less: accumulated amortization and translation	599.4				499.7
Intangible assets with definitive lives, net	$	1,396.4			$	1,512.4

Intangible assets with indefinite lives, net ⁽³⁾	8.9				8.9

Total other intangible assets, net	$	1,405.3			$	1,521.3

⁽³⁾Intangible assets with indefinite lives include trademark and technology intangible assets.

Remaining amortization expenses for intangible assets with definite lives

As of October 31, 2019, the estimation of amortization expenses for intangible assets with definite lives is as follows:



Fiscal years:	(In millions)
2020	$	135.8
2021	134.5
2022	132.7
2023	130.4
Thereafter	863.0
Total remaining amortization for intangible assets with definite lives	$	1,396.4